Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins - sprookjes - yvandenbroek - TriplyDB

Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins

Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins

http://www.wikidata.org/entity/Q24321922

about

Beneficial versus harmful effects of Angiotensin (1-7) on impulse propagation and cardiac arrhythmias in the failing heart Mechanisms of sudden cardiac death: oxidants and metabolism Upregulation of Angiotensin (1-7)-Mediated Signaling Preserves Endothelial Function Through Reducing Oxidative Stress in Diabetes.Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function Angiotensin-converting enzyme 2 as a novel target for gene therapy for hypertension Caveolin-1 modulates cardiac gap junction homeostasis and arrhythmogenecity by regulating cSrc tyrosine kinase.Angiotensin II reduces membranous angiotensin-converting enzyme 2 in pressurized human aortic endothelial cells.Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension Redox regulation, NF-kappaB, and atrial fibrillation.Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases.Mitochondria and arrhythmias.Mechanisms of sudden cardiac death.ACE2 improves right ventricular function in a pressure overload model.Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure Inhibition of renin-angiotensin system (RAS) reduces ventricular tachycardia risk by altering connexin43.Cardiac-restricted angiotensin-converting enzyme overexpression causes conduction defects and connexin dysregulation.Angiotensin-(1-7) abrogates mitogen-stimulated proliferation of cardiac fibroblasts.New fACEs to the renin-angiotensin system.Cardiovascular actions of angiotensin-(1-7).Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs.Neural modulation of cardiac arrhythmias and sudden cardiac death Effect of Angiotensin(1-7) on Heart Function in an Experimental Rat Model of Obesity Genetically altered animal models in the kallikrein-kinin system.The effect of amiodarone pretreatment on survival of mice with cocaine toxicity Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-myocardial ischemia.Genetically altered animal models for Mas and angiotensin-(1-7).Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats.Angiotensin-converting enzyme 2 in the brain: properties and future directions.Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia Genetic variation in angiotensin-converting enzyme-related pathways associated with sudden cardiac arrest risk.Cardiovascular protection by angiotensin-converting enzyme 2: a new paradigm.New pathways of the renin-angiotensin system: the role of ACE2 in cardiovascular pathophysiology and therapy.Regulation of cardiovascular remodeling by the counter-regulatory axis of the renin-angiotensin system.Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling.Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets.Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases.Atrial overexpression of angiotensin-converting enzyme 2 improves the canine rapid atrial pacing-induced structural and electrical remodeling. Fan, ACE2 improves atrial substrate remodeling.ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.

P2860

20e67c6f8381ece4184960312fb86e631e22f115

P248

Q24337673-D3889426-521E-466D-8A1F-A8E9FBCD8977 Q27024176-40D93127-04DF-4003-8F02-352F25DAC901 Q27308039-85151467-CE8B-47B8-9777-2A0F1C57616A Q28264715-D56B7AC0-F3E1-4466-9DFD-DA3B1D27E975 Q28301752-7A4BB3F0-273F-4DA5-A66F-5EA319BB451B Q29347261-2F9AD354-7C5E-470B-9C0F-F8FFCAAAA41F Q33443452-09A1E815-2BA9-4116-B28B-BA6604F533D8 Q33639490-6BEAD1AF-C641-46CA-92AC-35D8BE94D412 Q33644314-CAB4D3EE-01BC-401A-9994-4F7057A51644 Q33677369-21B3EA1C-24E4-4BC9-8D7C-7806E264B874 Q33896746-A39DAA04-AE12-4C11-AB8B-814979DF7EB4 Q33930892-5B6439DA-E6E7-4A0E-90BA-C1B729891E7E Q33939495-530812F5-AC2D-4FA7-B9E9-A33A36975670 Q34423315-6817A79B-A45A-44B1-96C0-98917C68083A Q34892110-30CAAF10-58F3-4E6D-BB45-A59618A689AD Q35165689-EB2F8380-2E9A-4753-A8E7-ED6BA171694F Q35176717-AA95AE23-EB1D-48E7-9DB4-2207D63174DD Q35889735-4B4E7A05-35FD-4E70-A9AD-F655F9104E9E Q36072691-86C7022D-DBC6-4728-9B78-AF0B74320D9A Q36165955-8EAAF0B4-25F2-4679-8585-02687105AC53 Q36210919-FAA689AA-E8B5-4D5B-8872-DFD6FCD88002 Q36362944-4F0DA904-5379-4949-9F05-36156488FA63 Q36387444-D9DD6FD7-DBAD-4BA1-AD0E-0EFC22B12D10 Q36404457-7AB83A5C-4FD8-4651-A44D-19C72211A52D Q36548317-1B7C74F3-7B90-4005-96BD-27592A0F5C03 Q36829137-E350AE54-0897-4520-B0C6-3C7EDEFF35E3 Q37044345-49354D86-A119-49A2-B340-60EA016D2664 Q37084921-080B5122-1BF3-498B-90E6-B486C7B93B54 Q37155907-7F03529E-6CE6-4769-BBD6-1B9E39B2F8DE Q37162741-DBBEF8D8-51E5-4681-9C54-4017C7FE0B0F Q37264704-53003D75-3012-432B-B5D2-A96F6B5FAE1F Q37375407-F581644D-0678-406E-A5FC-F0C42702EAAC Q37608588-7A1221B8-7E03-4B86-B18E-FEF93D20A43D Q37730859-7E9CF165-2036-478E-9DC9-2B8745D8A0A9 Q38069197-AFE3A1DD-0F5A-49C5-BD84-6D3E7A1580C6 Q38193206-E0BD82C0-870F-4D75-A963-D309D8183AC6 Q38207841-1E31FAC7-9F43-4E75-9B9A-C27DAF969835 Q38214892-E8688786-67C3-41C9-8D1F-0ECE439282D6 Q38413814-F3EF2868-F757-4DE4-9A26-B66BC8B9CAF1 Q38567063-87C840A1-6568-4B0D-803B-FB70A1F79E49

P2860

Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins

http://www.wikidata.org/entity/Q24321922

description

2003 nî lūn-bûn

@nan

2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Heart block, ventricular tachy ...... e with downregulated connexins

@ast

Heart block, ventricular tachy ...... e with downregulated connexins

@en

Heart block, ventricular tachy ...... e with downregulated connexins

@en-gb

Heart block, ventricular tachy ...... e with downregulated connexins

@nl

type

label

Heart block, ventricular tachy ...... e with downregulated connexins

@ast

Heart block, ventricular tachy ...... e with downregulated connexins

@en

Heart block, ventricular tachy ...... e with downregulated connexins

@en-gb

Heart block, ventricular tachy ...... e with downregulated connexins

@nl

prefLabel

Heart block, ventricular tachy ...... e with downregulated connexins

@ast

Heart block, ventricular tachy ...... e with downregulated connexins

@en

Heart block, ventricular tachy ...... e with downregulated connexins

@en-gb

Heart block, ventricular tachy ...... e with downregulated connexins

@nl

P1433

Q24321922-2F0BB3EF-486F-43DF-9A9A-CBE26FBFB99C

P1476

Q24321922-ACE148D1-12EB-42DE-8C0A-E35D2B3BB81C

P2093

Q24321922-10FD4D7D-29BD-4B59-99E7-07DB0A035A6C

Q24321922-1DCA491E-DE72-47DA-BFF1-FA78E32A505F

Q24321922-232CD14C-D387-4651-8CF9-0553086C2885

Q24321922-29790426-BFBF-4E03-B7F8-F6F2005653EB

Q24321922-6361750E-2EE6-4FA8-8FB0-13CFACFC8084

Q24321922-66BCC9C6-EA57-4553-830E-123412744D61

Q24321922-7A0D17AC-BB5B-4813-B57C-D2EB3DEA308A

Q24321922-8A1CAE14-B3AB-4D92-9821-5A554F2F1D25

Q24321922-8C1F05A8-D9B2-4ACC-BC39-E87A89724B07

Q24321922-A38F2C0F-7751-4FD3-B7F8-A535A92CE57D

P304

Q24321922-28D36BB1-CFBF-4005-BDA0-AD8C4572CA07

P31

Q24321922-FA36C9F3-9A82-4C22-A62B-F29335AF3ABA

P356

Q24321922-5C85111F-5BD1-4FA9-8D50-087B813B9889

P407

Q24321922-CC40EF6E-4858-495F-9265-28314865FE7E

P433

Q24321922-8EE63534-C89B-4BD5-ABC7-05B9415FE7A1

P478

Q24321922-5830539C-6DDF-4289-A602-1AA488AA0D8E

P577

Q24321922-A93D4008-31EA-4A98-931A-6447B8BECA27

P698

Q24321922-DCDE24F6-3CCA-494D-BA68-9D1BE5FD71B7

P921

Q24321922-0A819902-AC7C-489B-AFF2-A152393CCE0F

Q24321922-2BFFA9B6-B5F7-4DC5-AF6F-1E4A6255C4E9

Q24321922-60D12F24-01B8-412C-8773-BAA98BE2C13E

Q24321922-732F54CF-33CC-406B-9650-E58DA3AD6736

Q24321922-7CD3C59F-A8AB-4F43-9E3B-C7FB15D981B0

Q24321922-F711AD46-85D5-4F19-872C-0F92F11A6327

P356

S0022-2828(03)00177-9

P1433

Journal of Molecular and Cellular Cardiology

P1476

Heart block, ventricular tachy ...... e with downregulated connexins

@en

P2093

Charles I Berul

http://www.w3.org/2001/XMLSchema#string

Colin T Maguire

http://www.w3.org/2001/XMLSchema#string

Hiroko Wakimoto

http://www.w3.org/2001/XMLSchema#string

Jian Xu

http://www.w3.org/2001/XMLSchema#string

John N Lorenz

http://www.w3.org/2001/XMLSchema#string

Mary Donoghue

http://www.w3.org/2001/XMLSchema#string

Nancy Stagliano

http://www.w3.org/2001/XMLSchema#string

Paul Hales

http://www.w3.org/2001/XMLSchema#string

Roger E Breitbart

http://www.w3.org/2001/XMLSchema#string

Susan Acton

http://www.w3.org/2001/XMLSchema#string

P304

1043-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0022-2828(03)00177-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12967627

http://www.w3.org/2001/XMLSchema#string

P921

regulation of cardiac conduction

negative regulation of cardiac conduction

positive regulation of cardiac conduction

Angiotensin I converting enzyme 2